This is a citation of an outside article. Gravyday is not responsible for its content. Original URL below. How Does the AstraZeneca COVID-19 Vaccine Compare to Pfizer’s and Moderna’s? It’s cheaper, easier to distribute, and relies on very different tech than its competitors. The United Kingdom became the first country to approve AstraZeneca’s COVID-19 vaccine for emergency use on Dec. 30, just weeks after Pfizer’s and Moderna’s vaccine candidates received a green light from the Food and Drug Administration in the United States. The approval is another promising sign in the global immunization rollout—especially because this option, developed by Oxford University and biopharmaceutical company AstraZeneca, could be key to reaching people in rural and underfunded areas.(more)
